This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
11-13 November 2025
Congress Center BaselBasel, Switzerland
Book Now
Menu
Book

Floris van Delft, PhD
Head of R&D at Synaffix/Lonza
Speaker

Profile

Head of R&D at Synaffix/Lonza. Previously professor in organic chemistry at Radboud University and professor in bioconjugate chemistry at Wageningen University. Author of >150 scientific publications and >40 patent applications.

Agenda Sessions

  • GlycoConnect® Antibody-oligonucleotide Conjugates for Targeted Treatment of Neuromuscular Diseases

    , 08:35
    View Session

At this event

Prev
Next
Andreas Vegge, PhD
Project Vice President, Amycretin Cardiometabolics
Novo Nordisk

See Floris at TIDES Europe: Oligonucleotide and Peptide Therapeutics

Book Now